Japanese encephalitis-a pathological and clinical perspective - PubMed (original) (raw)
Japanese encephalitis-a pathological and clinical perspective
Debapriya Ghosh et al. PLoS Negl Trop Dis. 2009.
Abstract
Japanese encephalitis (JE) is the leading form of viral encephalitis in Asia. It is caused by the JE virus (JEV), which belongs to the family Flaviviridae. JEV is endemic to many parts of Asia, where periodic outbreaks take hundreds of lives. Despite the catastrophes it causes, JE has remained a tropical disease uncommon in the West. With rapid globalization and climatic shift, JEV has started to emerge in areas where the threat was previously unknown. Scientific evidence predicts that JEV will soon become a global pathogen and cause of worldwide pandemics. Although some research documents JEV pathogenesis and drug discovery, worldwide awareness of the need for extensive research to deal with JE is still lacking. This review focuses on the exigency of developing a worldwide effort to acknowledge the prime importance of performing an extensive study of this thus far neglected tropical viral disease. This review also outlines the pathogenesis, the scientific efforts channeled into develop a therapy, and the outlook for a possible future breakthrough addressing this killer disease.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Figure 1. The global distribution of JEV genotypes.
See –. The shaded areas indicate the present distribution of JEV, whereas the arrows indicate the areas where there is a high possibility of virus spread due to globalization and climatic change.
Figure 2. Events that lead to the establishment of JE pathogenesis.
Similar articles
- Changing Geographic Distribution of Japanese Encephalitis Virus Genotypes, 1935-2017.
Gao X, Liu H, Li X, Fu S, Cao L, Shao N, Zhang W, Wang Q, Lu Z, Lei W, He Y, Cao Y, Wang H, Liang G. Gao X, et al. Vector Borne Zoonotic Dis. 2019 Jan;19(1):35-44. doi: 10.1089/vbz.2018.2291. Epub 2018 Sep 12. Vector Borne Zoonotic Dis. 2019. PMID: 30207876 - Japanese encephalitis virus in India: An update on virus genotypes.
Rajaiah P, Kumar A. Rajaiah P, et al. Indian J Med Res. 2022 Oct-Nov;156(4&5):588-597. doi: 10.4103/ijmr.IJMR_2606_19. Indian J Med Res. 2022. PMID: 36926775 Free PMC article. Review. - Serological evidence of Japanese encephalitis virus infection in pigs in a low human incidence state, Goa, India.
Kumar HBC, Dhanze H, Bhilegaonkar KN, Chakurkar EB, Kumar A, Yathish HM. Kumar HBC, et al. Prev Vet Med. 2020 Feb;175:104882. doi: 10.1016/j.prevetmed.2020.104882. Epub 2020 Jan 3. Prev Vet Med. 2020. PMID: 31945550 - Axl Deficiency Promotes the Neuroinvasion of Japanese Encephalitis Virus by Enhancing IL-1α Production from Pyroptotic Macrophages.
Wang ZY, Zhen ZD, Fan DY, Qin CF, Han DS, Zhou HN, Wang PG, An J. Wang ZY, et al. J Virol. 2020 Aug 17;94(17):e00602-20. doi: 10.1128/JVI.00602-20. Print 2020 Aug 17. J Virol. 2020. PMID: 32611752 Free PMC article. - Shift in dominant genotypes of Japanese encephalitis virus and its impact on current vaccination strategies.
Xia Q, Yang Y, Zhang Y, Zhou L, Ma X, Xiao C, Zhang J, Li Z, Liu K, Li B, Shao D, Qiu Y, Wei J, Ma Z. Xia Q, et al. Front Microbiol. 2023 Nov 17;14:1302101. doi: 10.3389/fmicb.2023.1302101. eCollection 2023. Front Microbiol. 2023. PMID: 38045034 Free PMC article. Review.
Cited by
- Japanese encephalitis virus-induced DNA methylation contributes to blood-brain barrier permeability by modulating tight junction protein expression.
Xiang X, Yu D, Li Z, Fros JJ, Wei J, Liu K, Li Z, Shao D, Li B, Kortekaas J, van Oers MM, Ma Z, Pijlman GP, Qiu Y. Xiang X, et al. J Neuroinflammation. 2024 Oct 28;21(1):277. doi: 10.1186/s12974-024-03266-6. J Neuroinflammation. 2024. PMID: 39468601 Free PMC article. - A scoping review of evidence of naturally occurring Japanese encephalitis infection in vertebrate animals other than humans, ardeid birds and pigs.
Levesque ZA, Walsh MG, Webb CE, Zadoks RN, Brookes VJ. Levesque ZA, et al. PLoS Negl Trop Dis. 2024 Oct 4;18(10):e0012510. doi: 10.1371/journal.pntd.0012510. eCollection 2024 Oct. PLoS Negl Trop Dis. 2024. PMID: 39365832 Free PMC article. Review. - Screening a neurotransmitter-receptor-related inhibitor library identifies clomipramine HCl as a potential antiviral compound against Japanese encephalitis virus.
Liu Y, Wang X, Li Q, Zhu S, Zhu W, Chen H, Si Y, Zhu B, Cao S, Zhao Z, Ye J. Liu Y, et al. Infect Med (Beijing). 2024 Aug 13;3(3):100130. doi: 10.1016/j.imj.2024.100130. eCollection 2024 Sep. Infect Med (Beijing). 2024. PMID: 39309297 Free PMC article. - Impact of vaccination against Japanese encephalitis in endemic countries.
Letson GW, Marfin AA, Mooney J, Minh HV, Hills SL; JE Vaccine Global Impact Assessment Team. Letson GW, et al. PLoS Negl Trop Dis. 2024 Sep 3;18(9):e0012390. doi: 10.1371/journal.pntd.0012390. eCollection 2024 Sep. PLoS Negl Trop Dis. 2024. PMID: 39226312 Free PMC article. - Inflammatory & Apoptotic Factor Fluctuations Associated with Japanese Encephalitis Virus Infection in Transgenic IFNAR1-/- Mice.
Lin XH, Chowdhury D, Seo SH. Lin XH, et al. Curr Microbiol. 2024 Jun 23;81(8):239. doi: 10.1007/s00284-024-03759-w. Curr Microbiol. 2024. PMID: 38910205
References
- [No authors listed] Encephalitis outbreak kills 200 in India. The Sydney Morning Herald. 2008. Available: http://news.smh.com.au/world/encephalitis-outbreak-kills-200-in-india-20.... Accessed 2 July 2009.
- [No authors listed] JE bares its fangs in eastern UP. The Times of India. 2008. Available: http://timesofindia.indiatimes.com/articleshow/3266918.cms. Accessed 2 July 2009.
- Kaur R, Vrati S. Development of a recombinant vaccine against Japanese encephalitis. J Neurovirol. 2003;9:421–431. - PubMed
- Senior K. Is Japanese encephalitis control achievable by 2013? 2008. Available: http://www.path.org/projects/japanese_encephalitis_project_lancet.php. Accessed 2 July 2009.
- Elias C, Okwo-Bele JM, Fischer M. A strategic plan for Japanese encephalitis control by 2015. Lancet Infect Dis. 2009;9:7. - PubMed
LinkOut - more resources
Full Text Sources